简体中文 | 繁體中文 | English

Press Releases

2020-01-16 16:43 Jefferies to Dedicate a Day of Asia Pacific Trading in Support of Australia Wildfires Relief on Wednesday January 22
2020-01-16 16:37 AURAK Hosts Visit by South Korean Students
2020-01-16 14:42 Hitachi Chemical DuPont MicroSystems, Ltd.: Regarding the Decision to Maintain Two Japanese Granted Patents on Polyimide Precursor Resin Composition
2020-01-16 14:37 VIVOTEK and CyberLink Announce Strategic Partnership in Facial Recognition
2020-01-16 14:32 Bank of America Reports Fourth-Quarter 2019 Financial Results
2020-01-16 14:28 KAL and Česká Spořitelna Achieve World First with Kalignite Hypervisor ATM in Production
2020-01-16 14:15 Sheikh Mohammed bin Zayed Honours the 10 Winners of Zayed Sustainability Prize 2020
2020-01-16 09:56 NEC Qualifies 20 Fiber Pair Subsea Telecom Cable Systems, With Further Advances Soon
2020-01-16 09:51 Enevate Commercializing New Low Cost Battery Technology Providing Extreme Fast Charging and Long Range for Electric Vehicles
2020-01-16 09:46 Human Longevity Announces the Acquisition of DoctorsForMe
2020-01-16 09:43 AMR Life Science Industry 2020 Report: Successes and Setbacks in Fighting Superbugs
2020-01-16 09:35 Arthur D. Little Report Outlines Challenges and Opportunities for On-Demand Mobility
2020-01-15 18:36 Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska
2020-01-15 18:33 Axens and ExxonMobil Sign Alliance Agreement to Provide FLEXICOKING™ Technology and Integrated Resid Conversion Solutions
2020-01-15 16:40 Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-15 14:13 MPEG LA Introduces One-Stop License for Qi Wireless Power
2020-01-15 14:10 Ryland Sandford Consultants Says Tencent Recent Rally Is Worth Over $108 Billion
2020-01-15 13:55 LEGO® Education Celebrates 40 Years of Reimagining the Way Children Learn With New Hands-on STEAM Learning Solution
2020-01-15 13:50 Visa To Acquire Plaid
2020-01-15 11:43 GNT Pharma's Anti-dementia Drug 'crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia

Business Wire Weibo

Industries

Latest Releases